التفاصيل البيبلوغرافية
| العنوان: |
80O Patient (pt) preference and satisfaction with the subcutaneous fixed-dose combination of pertuzumab (P) and trastuzumab (H) in pts with HER2-positive early breast cancer (HER2+ eBC): Interim analysis of the open-label, randomised cross-over PHranceSCa study |
| المؤلفون: |
O'Shaughnessy, J., Sousa, S.P., Cruz, J., Fallowfield, L.J., Auvinen, P., Pulido, C., Cvetanovic, A., Wilks, S., Ribeiro, L., Burotto, M., Klingbiel, D., Messeri, D., Alexandrou, A., Trask, P., Fredriksson, J., Stamatovic, L. |
| المصدر: |
In Annals of Oncology May 2020 31 Supplement 2:S42-S42 |
| قاعدة البيانات: |
ScienceDirect |
